AI selects cancer patients who benefit from immunotherapy
Healthcare · Amsterdam · Founded 2019
What they build
Ellogon.AI is an Amsterdam-based MedTech startup specializing in AI applications for healthcare, particularly in cancer immunotherapy. The company develops predictive AI technology and automated biomarkers from pathology biopsies and genomic data to transform oncology drug development. Their flagship EIDOS™ solution assists medical experts in precisely selecting patients who are most likely to benefit from immunotherapy, aiming to improve patient outcomes and ensure accessible, affordable healthcare. Developed in collaboration with the Netherlands Cancer Institute, EIDOS™ is CE-IVDD certified and currently in use in four Dutch academic hospitals and one Greek hospital.
The people behind it
Who believes in them
Ellogon.AI raised €1M in total. The latest known round is Seed.
Where they are
Loading nearby…
Keep exploring